GLOBAL IMMUNE TECHNOLOGIES INC.
CIK 0001105284
Revenue (TTM)
—
Q2 Sep 2013
Net Income (TTM)
−$638.61K
−468.1% YoY
Q2 Sep 2013
EPS Diluted (TTM)
—
Q2 Sep 2013
Gross Margin
—
Q2 Sep 2013
Operating Margin
—
Q2 Sep 2013
Net Margin
—
Q2 Sep 2013
Free Cash Flow (TTM)
—
Q2 Sep 2013
Cash
$12.79K
Q2 Sep 2013
Total Debt
—
Q2 Sep 2013
Shares Outstanding
157.35M sh
Q2 Sep 2013
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.